Domestic Pharmaceutical Firms Set Aggressive Growth Plans for Next Year

As the domestic pharmaceutical industry is receiving a number of positive market expectations for the upcoming year, driven by such factors as continued market share increase by ethical generics, potential launchings of new drugs, and National Health Insurance (NHI) financial surplus, the majority of domestic pharmaceutical manufacturers are setting their overall business growth objectives as h...